Nurse Prescribing in Cancer Care 2017

Nurse Prescribing in Cancer Care is organized by Healthcare (HC) - UK Conferences and will be held on Dec 15, 2017 at De Vere West One, London, England, United Kingdom.

Conference Description :
This conference focuses on Nurse Prescribing in Cancer Care. Through national updates and practical case studies the conference will demonstrate how the effective use of nurse prescribing in cancer care can improve patient care, experience and outcomes.

The conference will focus on developing competence and confidence in nurse prescribing in cancer care, including using the new National Competency Framework for all Prescribers. Sessions will focus on chemotherapy prescribing, prescribing in a lung cancer, nurse prescribing for pain and symptom control, pharmacist prescribing within an oral anticancer medicine clinic, prescribing in end life care including controlled drugs, and nurse prescribing within follow up clinics and cancer survivorship services. The conference will also include a session on the development of radiographer led prescribing which has now been approved for advanced practice therapeutic radiographers.

Conference Objectives :
• Network with colleagues who are working to improve nurse prescribing practice in cancer care
• Understand the national context including the new national competency framework for prescribers
• Develop your skills and improve competence in prescribing practice
• Understand how to develop prescribing to improve chemotherapy services
• Improve your skills in the prescribing and prescribing governance
• Examine your role within prescribing at the end of life including symptom control and controlled drugs
• Learn from established prescribing practice in cancer follow up and survivorship, prescribing for lung cancer, pharmacist prescribing and radiographer prescribing
• Understand how to audit and demonstrate competence in nurse prescribing practice
• Self-assess and reflect on your own practice
• Gain CPD accreditation points contributing to professional development and evalidation evidence

Additional details will be posted as soon as they are available.